Phase 1 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men between the ages of 40 and 75
- Men who have at least one of the following risk factors: a PSA blood test result above 4.0 ng/ml, an abnormal prostate exam performed by a doctor using their finger (called a digital rectal exam), or a previous biopsy that found unusual but not clearly cancerous cells (a finding called ASAP)
- Men who have already had a specific type of prostate scan (called mpMRI or bpMRI), regardless of what the scan results showed
Who may not be able to join:
- People for whom a prostate scan result is not available
- Women and children, as this trial focuses specifically on prostate cancer
- People for whom a prostate biopsy is considered too risky — this includes those who have had previous rectal surgery, have a narrowing of the anal canal, have a blood-clotting disorder, or are currently taking blood-thinning medications such as Coumadin, Lovenox, or Heparin
- People for whom the local numbing injection used during the biopsy procedure is considered unsafe or not suitable
- People who have already had a prostate biopsy performed using the specific investigational device being studied in this trial (called the ProBot device)
- People from vulnerable groups, such as prisoners or those living in institutions
- People who are unwilling or unable to sign a consent form agreeing to take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Misop Han, MD, Johns Hopkins University
Phone: 410-502-5500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Device feasibility as assessed by patient discomfort score; Device feasibility as assessed by maximal procedural pain; Device feasibility as assessed by the rate of complications; Device feasibility as assessed by serious adverse events; Device feasibility as assessed by the rate of successful completion of cases; Device feasibility as assessed by the procedure time
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.